Viking Global Opportunities Parent GP LLC — SEC Form 4 filings
SEC reporting owner CIK 1886738. 9 Form 4 filings on record with FilingPulse; latest filed 2025-10-09.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-28 to 2025-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 5 filings — 11,906,015 shares, $450,810,614 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 3,500,000 shares @ $44.00 ($154,000,000) in BridgeBio Pharma, Inc., filed 2025-07-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | 10% owner | 2 | — | 2 legs · 6,565,616 sh · $260,989,998 | — |
| APi Group Corp (APG) | 10% owner | 3 | — | 4 legs · 4,990,399 sh · $178,533,116 | 6 |
| Inhibrx Biosciences, Inc. (INBX) | 10% owner | 1 | — | 3 legs · 350,000 sh · $11,287,500 | — |
| Inhibrx, Inc. (INBX) | 10% owner | 1 | — | — | 4 |
| RayzeBio, Inc. (RYZB) | 10% owner | 2 | — | — | 4 |
Form 4 filings — Viking Global Opportunities Parent GP LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-09 | 4 | Inhibrx Biosciences, Inc. (INBX) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 308,643 @ $32.25 · Sale (S): 16,315 @ $32.25 · Sale (S): 25,042 @ $32.25 | EDGAR |
| 2025-07-01 | 4 | BridgeBio Pharma, Inc. (BBIO) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 3,500,000 @ $44 | EDGAR |
| 2025-01-31 | 4 | BridgeBio Pharma, Inc. (BBIO) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 3,065,616 @ $34.90 | EDGAR |
| 2024-06-18 | 4 | APi Group Corp (APG) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 1,912,750 @ $38.15 · Sale (S): 39,032 @ $38.15 | EDGAR |
| 2024-06-03 | 4 | Inhibrx, Inc. (INBX) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Other (J): 6,305,866 @ $30 · Other (J): 333,333 @ $30 · Other (J): 511,627 @ $30 · Other (J): 1,038,765 (derivative) @ $30 | EDGAR |
| 2024-03-07 | 4 | APi Group Corp (APG) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 2,977,845 @ $34.25 · Sale (S): 60,772 @ $34.25 | EDGAR |
| 2024-03-01 | 4 | APi Group Corp (APG) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Conversion (C): 8,036,862 @ $24.60 · Conversion (C): 164,016 @ $24.60 · Other (J): 3,983,739 @ $36.90 · Other (J): 81,300 @ $36.90 · Conversion (C): 196,000 (derivative) @ $0 · Conversion (C): 4,000 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | RayzeBio, Inc. (RYZB) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Other (J): 4,899,144 · Other (J): 1,743,556 | EDGAR |
| 2024-02-28 | 4 | RayzeBio, Inc. (RYZB) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Drawdown GP LLC, Viking Global Opportunities Drawdown Portfolio GP LLC, Viking Global Opportunities Drawdown (Aggregator) LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Other (J): 4,899,144 · Other (J): 1,743,556 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1886738 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →